Literature DB >> 7705836

Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism.

C Tournamille1, C Le Van Kim, P Gane, J P Cartron, Y Colin.   

Abstract

The Duffy blood group antigens are carried by the erythrocyte membrane glycoprotein gpD, which has a molecular weight of 35-45 kDa and which has been recently cloned. In this report, we have determined, at the nucleic acid level, the molecular basis for the blood group Fya/Fyb polymorphism. The gpD cDNAs isolated by reverse transcription/polymerase chain reaction (RT-PCR) from Fy(a+b-) and Fy(a-b+) donors differed by only one base substitution (G131A) changing Gly to Asp at position 44 of the gpD protein. When expressed in simian Cos-7 cells, the Gy(a+b-) and Fy(a-b+) gpD cDNA produce cell surface proteins that react with the anti-Fya and anti-Fyb antisera, respectively, demonstrating that they represent the FY*A and FY*B alleles of the Duffy blood group locus. The G131A nucleotide substitution has been correlated with a BanI restriction site polymorphism, which has allowed us to develop a method for the DNA typing of the main Duffy blood group antigens, by means of PCR/restriction fragment length polymorphisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705836     DOI: 10.1007/bf00208965

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  12 in total

1.  Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor.

Authors:  K Neote; J Y Mak; L F Kolakowski; T J Schall
Journal:  Blood       Date:  1994-07-01       Impact factor: 22.113

2.  Probable assignment of the Duffy blood group locus to chromosome 1 in man.

Authors:  R P Donahue; W B Bias; J H Renwick; V A McKusick
Journal:  Proc Natl Acad Sci U S A       Date:  1968-11       Impact factor: 11.205

3.  Prenatal determination of fetal RhD type by DNA amplification.

Authors:  P R Bennett; C Le Van Kim; Y Colin; R M Warwick; B Chérif-Zahar; N M Fisk; J P Cartron
Journal:  N Engl J Med       Date:  1993-08-26       Impact factor: 91.245

4.  Production of a new murine monoclonal antibody with Fy6 specificity and characterization of the immunopurified N-glycosylated Duffy-active molecule.

Authors:  S Riwom; D Janvier; J M Navenot; M Benbunan; J Y Muller; D Blanchard
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

5.  The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy.

Authors:  L H Miller; S J Mason; D F Clyde; M H McGinniss
Journal:  N Engl J Med       Date:  1976-08-05       Impact factor: 91.245

6.  PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease.

Authors:  C Le Van Kim; I Mouro; Y Brossard; J Chavinié; J P Cartron; Y Colin
Journal:  Br J Haematol       Date:  1994-09       Impact factor: 6.998

7.  Molecular genetic basis of the human Rhesus blood group system.

Authors:  I Mouro; Y Colin; B Chérif-Zahar; J P Cartron; C Le Van Kim
Journal:  Nat Genet       Date:  1993-09       Impact factor: 38.330

8.  Cloning of glycoprotein D cDNA, which encodes the major subunit of the Duffy blood group system and the receptor for the Plasmodium vivax malaria parasite.

Authors:  A Chaudhuri; J Polyakova; V Zbrzezna; K Williams; S Gulati; A O Pogo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

9.  In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax.

Authors:  J W Barnwell; M E Nichols; P Rubinstein
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  A new human Duffy blood group specificity defined by a murine monoclonal antibody. Immunogenetics and association with susceptibility to Plasmodium vivax.

Authors:  M E Nichols; P Rubinstein; J Barnwell; S Rodriguez de Cordoba; R E Rosenfield
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  25 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

2.  Cloning, characterization, and mapping of a murine promiscuous chemokine receptor gene: homolog of the human Duffy gene.

Authors:  H Luo; A Chaudhuri; K R Johnson; K Neote; V Zbrzezna; Y He; A O Pogo
Journal:  Genome Res       Date:  1997-09       Impact factor: 9.043

3.  Shedding light on DARC: the role of the Duffy antigen/receptor for chemokines in inflammation, infection and malignancy.

Authors:  K Horne; Ian J Woolley
Journal:  Inflamm Res       Date:  2009-03-17       Impact factor: 4.575

4.  Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea.

Authors:  P A Zimmerman; I Woolley; G L Masinde; S M Miller; D T McNamara; F Hazlett; C S Mgone; M P Alpers; B Genton; B A Boatin; J W Kazura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  ACKR1 Alleles at 5.6 kb in a Well-Characterized Renewable US Food and Drug Administration (FDA) Reference Panel for Standardization of Blood Group Genotyping.

Authors:  Kshitij Srivastava; Pavel P Khil; Emilia Sippert; Evgeniya Volkova; John P Dekker; Maria Rios; Willy A Flegel
Journal:  J Mol Diagn       Date:  2020-07-17       Impact factor: 5.568

6.  Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people.

Authors:  Didier Ménard; Céline Barnadas; Christiane Bouchier; Cara Henry-Halldin; Laurie R Gray; Arsène Ratsimbasoa; Vincent Thonier; Jean-François Carod; Olivier Domarle; Yves Colin; Olivier Bertrand; Julien Picot; Christopher L King; Brian T Grimberg; Odile Mercereau-Puijalon; Peter A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-15       Impact factor: 11.205

7.  Characterization of Plasmodium vivax transmission-blocking activity in low to moderate malaria transmission settings of the Colombian Pacific coast.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Leonardo Rocha; Diego Alvarez; John C Beier; Sócrates Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 8.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

Review 9.  Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention.

Authors:  J Alexandra Rowe; D Herbert Opi; Thomas N Williams
Journal:  Curr Opin Hematol       Date:  2009-11       Impact factor: 3.284

10.  Sequence, evolution and ligand binding properties of mammalian Duffy antigen/receptor for chemokines.

Authors:  Christophe Tournamille; Antoine Blancher; Caroline Le Van Kim; Pierre Gane; Pol André Apoil; Wilson Nakamoto; Jean Pierre Cartron; Yves Colin
Journal:  Immunogenetics       Date:  2004-01-08       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.